A new management brief from Microtest Laboratories recommends that medical device manufacturers use notebook studies to help ensure successful reusable device cleaning validations. The lab bases the advice on its performance of validations for various types of medical instruments over the years.
The brief discusses the document, FDA Draft Guidance for Industry and Staff, Processing/Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling, which was released in May 2011.
Even though its labeled as a draft, experience has shown that most reusable device cleaning validations are being evaluated based on this document, says Patrick Kenny, manager of analytical services at Microtest Laboratories and author of the new brief titled, Notebook Studies to Ensure Successful Reusable Device Cleaning Validations.
Kennys brief focuses on areas of the FDA guidance document that are causing difficulties in cleaning validations, and demonstrates how pre-validation laboratory work can help save time and money. It also identifies areas that can cause issues during validations if they are not thoroughly addressed prior to initiating the protocol. These include:
 The use of worst-case conditions
 The switch from microbial-based assays to chemical-based assays
 The determination of an acceptable residual level
 The validation of a reusable devices cleaning instructions
The good news is that almost all of these issues can be eliminated with some up-front work, Kenny says. And this preparatory work can best be performed by notebook studies prior to initiating GLP studies. The information obtained in these relatively quick studies often saves significant time later in the filing process. In short, we recommend the use of notebook studies prior to beginning the validation to eliminate as many unknowns as possible."
To obtain a copy of the new management brief, Notebook Studies to Ensure Successful Reusable Device Cleaning Validations, visit http://www.microtestlabs.com/notebook-studies-brief or call 1-413-786-1680, or toll-free 1-800-631-1680.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.